topiramate

NDC 67046-1202 · Coupler LLC

Generic nametopiramate

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength50 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

67046-1202-3 — 30 TABLET, FILM COATED in 1 BLISTER PACK (67046-1202-3)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65862-171 — Topiramate, 65862-172 — Topiramate, 65862-173 — Topiramate, 65862-174 — Topiramate, 66993-780 — phentermine and topiramate, 66993-781 — phentermine and topiramate, 66993-782 — phentermine and topiramate, 66993-783 — phentermine and topiramate, 67046-0375 — topiramate, 67046-1180 — topiramate, 67046-1688 — Topiramate, 67046-1691 — topiramate, 67877-833 — TOPIRAMATE, 67877-868 — Topiramate, 67877-869 — Topiramate, 68071-1971 — Topiramate, 68071-3088 — Topiramate, 68071-3660 — topiramate, 68071-4760 — topiramate, 68071-4877 — topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels